No Data
No Data
Biodexa Pharmaceuticals Adjusts Share Value Amid Drug Development Focus
Biodexa Pharmaceuticals Announces Result of General Meeting
Express News | Biodexa Pharmaceuticals Shares Halted To The Upside; Stock Now Up 48.57%
Gaining Momentum, Biodexa Is Advancing Two Recent Acquisitions Through the Clinic
ADRs End Lower; Barinthus Biotherapeutics PLC Declines 30%
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading